Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Current Assets (2016 - 2025)

Cosmos Health's Current Assets history spans 13 years, with the latest figure at $38.4 million for Q4 2025.

  • Quarterly results put Current Assets at $38.4 million for Q4 2025, up 50.77% from a year ago — trailing twelve months through Dec 2025 was $38.4 million (up 50.77% YoY), and the annual figure for FY2025 was $38.4 million, up 50.77%.
  • Current Assets for Q4 2025 was $38.4 million at Cosmos Health, up from $38.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $56.4 million in Q4 2022 to a low of $25.5 million in Q4 2024.
  • The 5-year median for Current Assets is $38.7 million (2021), against an average of $39.2 million.
  • The sharpest move saw Current Assets surged 85.37% in 2021, then tumbled 35.05% in 2023.
  • Year by year, Current Assets stood at $39.8 million in 2021, then soared by 41.51% to $56.4 million in 2022, then tumbled by 35.05% to $36.6 million in 2023, then crashed by 30.45% to $25.5 million in 2024, then surged by 50.77% to $38.4 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $38.4 million, $38.1 million, and $30.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.